Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34270825/

doi: 10.1111/ejh.13690. Online ahead of print. 1 Medizinische Klinik, München Klinik Schwabing, Munich, Germany. 2 Asklepios Tumorzentrum Hamburg, AK Altona und AK St. Georg, Hamburg, Germany. 3 Medizinische Klinik und Poliklinik II, Julius Maximilians Universität Würzburg, Würzburg, Germany. 4 Janssen-Cilag GmbH, Neuss, Germany. 5 acromion GmbH, Frechen, Germany.